Revenue declined 3% year-over-year, with EBITDA down 4.4% and recurring headline EPS down 9.4%. Debt and working capital improved, and the dividend was maintained. F25 is expected to miss PBT targets, but the F30 plan is on track, with increased CapEx and a positive outlook as market conditions improve.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.